202 related articles for article (PubMed ID: 11509936)
1. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation.
Hiraoka A; Ohashi Y; Okamoto S; Moriyama Y; Nagao T; Kodera Y; Kanamaru A; Dohy H; Masaoka T;
Bone Marrow Transplant; 2001 Jul; 28(2):181-5. PubMed ID: 11509936
[TBL] [Abstract][Full Text] [Related]
2. Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Kalhs P; Brugger S; Schwarzinger I; Greinix HT; Keil F; Kyrle PA; Knöbl P; Schneider B; Höcker P; Linkesch W
Transplantation; 1995 Nov; 60(9):949-57. PubMed ID: 7491699
[TBL] [Abstract][Full Text] [Related]
3. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
Atkinson K; Downs K
Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
[TBL] [Abstract][Full Text] [Related]
4. Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.
Ringdén O; Klaesson S; Sundberg B; Ljungman P; Lönnqvist B; Persson U
Bone Marrow Transplant; 1992 Jan; 9(1):19-25. PubMed ID: 1543946
[TBL] [Abstract][Full Text] [Related]
5. Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporin A.
Locatelli F; Uderzo C; Dini G; Zecca M; Arcese W; Messina C; Andolina M; Miniero R; Porta F; Rovelli A
Bone Marrow Transplant; 1993 Dec; 12(6):627-33. PubMed ID: 8136746
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Schwinghammer TL; Bloom EJ
Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
[TBL] [Abstract][Full Text] [Related]
7. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Kanamaru A; Takemoto Y; Kakishita E; Dohy H; Kodera Y; Moriyama Y; Shibata A; Kasai M; Katoh S; Saitoh H
Bone Marrow Transplant; 1995 Jun; 15(6):885-9. PubMed ID: 7581086
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of graft-versus-host disease in identical sibling donor bone marrow transplant by anti-IL-2 receptor monoclonal antibody LO-Tact-1.
Ferrant A; Latinne D; Bazin H; Straetmans N; Cornet A; de la Parra B; Michaux JL
Bone Marrow Transplant; 1995 Oct; 16(4):577-81. PubMed ID: 8528175
[TBL] [Abstract][Full Text] [Related]
9. Immunomagnetic CD4+ and CD8+ cell depletion for patients at high risk for severe acute GVHD.
Jansen J; Hanks S; Akard LP; Thompson JM; Burns S; Chang Q; English D; Garrett P
Bone Marrow Transplant; 1996 Mar; 17(3):377-82. PubMed ID: 8704690
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.
Cahn JY; Bordigoni P; Tiberghien P; Milpied N; Brion A; Widjenes J; Lioure B; Michel G; Burdach S; Kolb HJ
Transplantation; 1995 Nov; 60(9):939-42. PubMed ID: 7491697
[TBL] [Abstract][Full Text] [Related]
11. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.
Fay JW; Wingard JR; Antin JH; Collins RH; Piñeiro LA; Blazar BR; Saral R; Bierer BE; Przepiorka D; Fitzsimmons WE; Maher RM; Weisdorf DJ
Blood; 1996 Apr; 87(8):3514-9. PubMed ID: 8605372
[TBL] [Abstract][Full Text] [Related]
12. Using elutriation to engineer bone marrow allografts.
Noga SJ; Wagner JE; Rowley SD; Davis JM; Vogelsang GB; Hess AD; Saral R; Santos GW; Donnenberg AD
Prog Clin Biol Res; 1990; 333():345-59; discussion 360-1. PubMed ID: 2137932
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Remberger M; Ringden O; Aschan J; Ljungman P; Lönnqvist B; Markling L
Transplant Proc; 1994 Jun; 26(3):1829-30. PubMed ID: 8030159
[No Abstract] [Full Text] [Related]
14. High-dose cyclosporine and corticosteroids for prophylaxis of acute and chronic graft-versus-host disease.
Schwinghammer TL; Bloom EJ; Rosenfeld CS; Wilson JW; Przepiorka D; Shadduck RK
Bone Marrow Transplant; 1995 Jul; 16(1):147-54. PubMed ID: 7581115
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial of tacrolimus versus cyclosporine in lung transplantation.
Keenan RJ; Konishi H; Kawai A; Paradis IL; Nunley DR; Iacono AT; Hardesty RL; Weyant RJ; Griffith BP
Ann Thorac Surg; 1995 Sep; 60(3):580-4; discussion 584-5. PubMed ID: 7545889
[TBL] [Abstract][Full Text] [Related]
16. [Recent progress in treatment and prophylaxis of graft-versus-host disease].
Kato S; Yabe H
Rinsho Ketsueki; 1995 Jun; 36(6):538-42. PubMed ID: 7643447
[TBL] [Abstract][Full Text] [Related]
17. Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation.
Haanen C; De Witte T; Plas A; Schattemberg T
Haematologica; 1991 Mar; 76 Suppl 1():22-8. PubMed ID: 1864551
[TBL] [Abstract][Full Text] [Related]
18. [Allogeneic bone marrow transplantation].
Shibata H
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3044-52. PubMed ID: 3056276
[TBL] [Abstract][Full Text] [Related]
19. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.
Koehler MT; Howrie D; Mirro J; Neudorf S; Blatt J; Corey S; Wollman M; Kelly-Ekeroth V; Reyes J
Bone Marrow Transplant; 1995 Jun; 15(6):895-9. PubMed ID: 7581088
[TBL] [Abstract][Full Text] [Related]
20. [Graft vs host disease in a child undergoing allogeneic bone marrow transplantation].
Nespoli L; Locatelli F
Pediatr Med Chir; 1991; 13(1):17-23. PubMed ID: 2052451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
